Sharp to package Alnylam RNAi therapeutics for Europe at Belgian site
Alnylam Pharmaceuticals and Sharp agreed that Sharp's Hamont-Achel site in Belgium will package all Alnylam products across European countries. Alnylam describes it as its first significant international investment in Belgium.
